BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26010758)

  • 21. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal microbiota transplantation alleviated Alzheimer's disease-like pathogenesis in APP/PS1 transgenic mice.
    Sun J; Xu J; Ling Y; Wang F; Gong T; Yang C; Ye S; Ye K; Wei D; Song Z; Chen D; Liu J
    Transl Psychiatry; 2019 Aug; 9(1):189. PubMed ID: 31383855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice.
    Hooijmans CR; Van der Zee CE; Dederen PJ; Brouwer KM; Reijmer YD; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Kiliaan AJ
    Neurobiol Dis; 2009 Mar; 33(3):482-98. PubMed ID: 19130883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain Injury.
    Ferguson S; Mouzon B; Paris D; Aponte D; Abdullah L; Stewart W; Mullan M; Crawford F
    J Neurotrauma; 2017 Apr; 34(8):1676-1691. PubMed ID: 27889957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology.
    Xiang Z; Ho L; Valdellon J; Borchelt D; Kelley K; Spielman L; Aisen PS; Pasinetti GM
    Neurobiol Aging; 2002; 23(3):327-34. PubMed ID: 11959394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.
    Ding Y; Qiao A; Wang Z; Goodwin JS; Lee ES; Block ML; Allsbrook M; McDonald MP; Fan GH
    J Neurosci; 2008 Nov; 28(45):11622-34. PubMed ID: 18987198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
    Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
    J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
    Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR
    Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
    Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of transient receptor potential ankyrin 1 channels in Alzheimer's disease.
    Lee KI; Lee HT; Lin HC; Tsay HJ; Tsai FC; Shyue SK; Lee TS
    J Neuroinflammation; 2016 Apr; 13(1):92. PubMed ID: 27121378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibiting α1-adrenergic receptor signaling pathway ameliorates AD-type pathologies and behavioral deficits in APPswe/PS1 mouse model.
    Yu ZY; Yi X; Wang YR; Zeng GH; Tan CR; Cheng Y; Sun PY; Liu ZH; Wang YJ; Liu YH
    J Neurochem; 2022 May; 161(3):293-307. PubMed ID: 35244207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J
    Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CART treatment improves memory and synaptic structure in APP/PS1 mice.
    Jin JL; Liou AK; Shi Y; Yin KL; Chen L; Li LL; Zhu XL; Qian L; Yang R; Chen J; Xu Y
    Sci Rep; 2015 May; 5():10224. PubMed ID: 25959573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term (15 mo) dietary supplementation with pomegranates from Oman attenuates cognitive and behavioral deficits in a transgenic mice model of Alzheimer's disease.
    Subash S; Braidy N; Essa MM; Zayana AB; Ragini V; Al-Adawi S; Al-Asmi A; Guillemin GJ
    Nutrition; 2015 Jan; 31(1):223-9. PubMed ID: 25441596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial biogenesis mediated by melatonin in an APPswe/PS1dE9 transgenic mice model.
    Song C; Li M; Xu L; Shen Y; Yang H; Ding M; Liu X; Xie Z
    Neuroreport; 2018 Dec; 29(18):1517-1524. PubMed ID: 30303857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.